The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship between lymphopenia and objective response rate with programmed death-1 (PD-1) inhibitor therapy: A single-center retrospective analysis.
 
Mark Yarchoan
Stock and Other Ownership Interests - ChemoCentryx; Dexcom; Exelixis; Macrogenics; Newlink Genetics; Seagen; Xencor
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Case Western University; Case Western University (I)
 
Adam Diehl
No Relationships to Disclose
 
Burles Avner Johnson
No Relationships to Disclose
 
Blake Scott
Research Funding - Corvus Pharmaceuticals (Inst)
 
Alexander Hopkins
No Relationships to Disclose
 
Nilofer Saba Azad
Honoraria - Bayer/Onyx
Consulting or Advisory Role - Dava Oncology
Research Funding - Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Genentech (Inst); Kinex (Inst); Precision Biologics (Inst)
 
Elizabeth M. Jaffee
Consulting or Advisory Role - MedImmune
Research Funding - Aduro Biotech
Patents, Royalties, Other Intellectual Property - Aduro Biotech
 
Stuart A. Grossman
Stock and Other Ownership Interests - Axxia Pharmaceuticals
Consulting or Advisory Role - Abbvie; Medicenna; Midatech Pharma
Patents, Royalties, Other Intellectual Property - Patent related to a subcutaneous polymeric opioid delivery system have been awarded.